Pareto, Deborah http://orcid.org/0000-0001-7356-3769
Sastre-Garriga, Jaume
Alberich, Manel
Auger, Cristina
Tintoré, Mar
Montalban, Xavier
Rovira, Àlex
Funding for this research was provided by:
This study was partially supported by Novartis Farmacéutica S.A., Barcelona (Spain). (n/a)
Article History
Received: 25 September 2018
Accepted: 18 February 2019
First Online: 5 March 2019
Compliance with ethical standards
:
: DP has received speaking honoraria from Sanofi-Genzyme. JS-G has received travel and accommodation grants from Merck, Novartis, TEVA, Celgene, Roche, Sanofi and Excemed. MA has been sponsored by Novartis Farmacéutica S.A., Barcelona (Spain). CA has received speaking honoraria from Novartis, Stendhal and Biogen. MT has received speaking honoraria and travel expenses from Amirall, Bayer, Biogen Idec, Genzyme, Merck Serono, Novartis, Sanofi-Aventis, Roche and Teva. XM has received speaking honoraria and travel expenses, and has been a steering committee member of clinical trials or participated in advisory boards of clinical trials for Actelion, Almirall, Bayer, Biogen, Celgene, Hoffmann-La Roche, Merck, Novartis, Oryzon Genomics, Sanofi-Genzyme and Teva Pharmaceutical. AR has served/s on scientific advisory boards for Novartis, Sanofi-Genzyme, Icometrix, and OLEA Medical, and has received speaker honoraria from Bayer, Sanofi-Genzyme, Bracco, Merck-Serono, Teva Pharmaceutical Industries Ltd., Novartis, Roche and Biogen Idec.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.